Peripheral Embolization Coils Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Detachable Coil and Pushable Coil), Material (Platinum, Platinum and Hydrogel, and Platinum Tungsten Alloy), Application (Bleeding and Trauma, Malformations, Tumors, Visceral Aneurysm, Endoleak Type II, and Varicose Veins), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

The peripheral embolization coils market size is projected to reach US$ 613.96 million by 2031 from US$ 433.06 million in 2023. The market is expected to register a CAGR of 4.5% during 2023–2031. The growing importance of packing density is likely to remain a key trend in the peripheral embolization coils market.

Peripheral Embolization Coils Market Analysis

A rise in the prevalence of aortic aneurysms and an increase in the incidence of cancer are the key factors driving the peripheral embolization coils market. New product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Peripheral Embolization Coils Market Overview

Embolization procedures have become an integral part of interventional radiology treatments. A peripheral coil embolization system is used to treat vascular illnesses such as bleeding and trauma, aneurysms [arteriovenous malformations (AVMs)], tumors, and others. The platinum coil peripheral embolization system is most commonly used to treat extracerebral aneurysms and internal carotid aneurysms. An extracerebral aneurysm is a hemangioma that develops in one of the extracerebral arteries, such as the carotid or skull base artery. It is a common vascular abnormality that is prone to rupture, resulting in catastrophic complications such as stroke and hemorrhage.

Peripheral Embolization Coils Market Drivers and Opportunities

Increase in Incidence of Cancer Favors Market Growth

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Expanding Range of Applications of Embolization Coils to Create Notable Opportunities in Future

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approvals, which help them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below.

In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy.

Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Peripheral Embolization Coils Market Report Segmentation Analysis

Key segments that contributed to the derivation of the peripheral embolization coils market analysis are type, material, and application.

• By type, the market is bifurcated into pushable coil and detachable coil. In 2023, the detachable coil segment held a larger share of the market.
• Based on material, the peripheral embolization coils market is segmented into platinum, platinum and hydrogel, and platinum tungsten alloy. In 2023, the platinum segment held the largest share of the market and is estimated to register the highest CAGR during the forecast period.
• By application, the market is divided into bleeding and trauma, malformations, tumors, visceral aneurysms, endoleak type II, and varicose veins. In 2023, the bleeding and trauma segment held the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period.

Peripheral Embolization Coils Market Share Analysis by Geography

The geographic scope of the peripheral embolization coils market report encompasses five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Europe dominated the peripheral embolization coils market in 2023. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation.

Peripheral Embolization Coils Market Regional Insights

The regional trends and factors influencing the Peripheral Embolization Coils Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Peripheral Embolization Coils Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Peripheral Embolization Coils Market Report Scope

Peripheral Embolization Coils Market Players Density: Understanding Its Impact on Business Dynamics

The Peripheral Embolization Coils Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Peripheral Embolization Coils Market are:

1. Medtronic Plc,
2. Penumbra Inc.,
3. Balt,
4. Boston Scientific Corp,
5. Cook Medical Holdings LLC,
6. Wallaby Medical,

Disclaimer: The companies listed above are not ranked in any particular order.

Peripheral Embolization Coils Market News and Recent Developments

The peripheral embolization coils market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are mentioned below:

• Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval for its ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System from the National Medical Products Administration (NMPA). ZYLOX Phoenix is a proprietary medical device independently developed by the company for the minimally invasive interventional treatment of peripheral arterial embolism. (ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD., Press Release, January 2024)
• Boston Scientific Corporation received US Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. (Coloplast Group, Press Release, April 2022)
• Wallaby Medical announced the acquisition of phenox GmbH—including femtos GmbH (femtos), a Germany-based global innovation and technology leader in the neurovascular space. The acquisition has been one of the world’s largest cross-border transactions in the medical device industry in recent years. It would enable the combined company to leverage the broad geographic coverage and product portfolio of participant companies to become a global leader in providing a wide range of neurovascular technologies and solutions to its customers and patients in the US, China, Europe, Japan, and other international markets. (Wallaby Medical, Press Release, April 2022)
• Wallaby Medical Holding, Inc. received approval from the National Medical Products Administration (NMPA) to market its Avenir Plus Coil System in China. The product was developed independently by Wallaby with the objective of safely and efficiently achieving a dense packing of aneurysms, isolating them from blood flow, and lowering the risk of future rupture or re-rupture. Smaller, softer coils included in the new Avenir Plus Coil System assist physicians in achieving such dense packing. (Wallaby Medical, Press Release, April 2022)

Peripheral Embolization Coils Market Report Coverage and Deliverables

The “Peripheral Embolization Coils Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

• Peripheral embolization coils market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Peripheral embolization coils market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Peripheral embolization coils market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the peripheral embolization coils market
• Detailed company profiles

The List of Companies - Peripheral Embolization Coils Market

1. Sonic Healthcare Ltd
2. UNILABS
3. Laboratory Corp of America Holdings
4. Quest Diagnostics Inc
5. ARUP Laboratories Inc
6. Clinical Reference Laboratory Inc
7. SYNLAB International GmbH
8. Myraid Genetics Inc
9. Boca Biolistics LLC
10. TOPLAB

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the peripheral embolization coils market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global peripheral embolization coils market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global peripheral embolization coils market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.